SNPX
Price
$6.04
Change
+$1.15 (+23.47%)
Updated
Jun 27 closing price
Capitalization
8.4M
ZVSA
Price
$0.71
Change
+$0.03 (+4.41%)
Updated
Jun 27 closing price
Capitalization
3.36M
Interact to see
Advertisement

SNPX vs ZVSA

Header iconSNPX vs ZVSA Comparison
Open Charts SNPX vs ZVSABanner chart's image
Synaptogenix
Price$6.04
Change+$1.15 (+23.47%)
Volume$741.78K
Capitalization8.4M
ZyVersa Therapeutics
Price$0.71
Change+$0.03 (+4.41%)
Volume$453.98K
Capitalization3.36M
SNPX vs ZVSA Comparison Chart in %
Loading...
SNPX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ZVSA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
SNPX vs. ZVSA commentary
Jun 29, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is SNPX is a Buy and ZVSA is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 29, 2025
Stock price -- (SNPX: $6.05 vs. ZVSA: $0.71)
Brand notoriety: SNPX and ZVSA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: SNPX: 64% vs. ZVSA: 18%
Market capitalization -- SNPX: $8.4M vs. ZVSA: $3.36M
SNPX [@Biotechnology] is valued at $8.4M. ZVSA’s [@Biotechnology] market capitalization is $3.36M. The market cap for tickers in the [@Biotechnology] industry ranges from $299.85B to $0. The average market capitalization across the [@Biotechnology] industry is $2.3B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

SNPX’s FA Score shows that 2 FA rating(s) are green whileZVSA’s FA Score has 1 green FA rating(s).

  • SNPX’s FA Score: 2 green, 3 red.
  • ZVSA’s FA Score: 1 green, 4 red.
According to our system of comparison, SNPX is a better buy in the long-term than ZVSA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

SNPX’s TA Score shows that 6 TA indicator(s) are bullish while ZVSA’s TA Score has 6 bullish TA indicator(s).

  • SNPX’s TA Score: 6 bullish, 2 bearish.
  • ZVSA’s TA Score: 6 bullish, 3 bearish.
According to our system of comparison, SNPX is a better buy in the short-term than ZVSA.

Price Growth

SNPX (@Biotechnology) experienced а +40.58% price change this week, while ZVSA (@Biotechnology) price change was +10.28% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.13%. For the same industry, the average monthly price growth was +31.22%, and the average quarterly price growth was +12.91%.

Industries' Descriptions

@Biotechnology (+4.13% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SNPX($8.4M) has a higher market cap than ZVSA($3.36M). SNPX has higher P/E ratio than ZVSA: SNPX (2.75) vs ZVSA (0.00). SNPX YTD gains are higher at: 74.207 vs. ZVSA (-32.792). SNPX has higher annual earnings (EBITDA): -6.18M vs. ZVSA (-8.44M). SNPX has more cash in the bank: 14.8M vs. ZVSA (1.61M). SNPX (0) and ZVSA (0) have equivalent revenues.
SNPXZVSASNPX / ZVSA
Capitalization8.4M3.36M250%
EBITDA-6.18M-8.44M73%
Gain YTD74.207-32.792-226%
P/E Ratio2.750.00217,736%
Revenue00-
Total Cash14.8M1.61M918%
Total DebtN/A0-
TECHNICAL ANALYSIS
Technical Analysis
SNPXZVSA
RSI
ODDS (%)
Bearish Trend 3 days ago
87%
N/A
Stochastic
ODDS (%)
Bullish Trend 3 days ago
86%
Bullish Trend 3 days ago
71%
Momentum
ODDS (%)
Bullish Trend 3 days ago
88%
Bearish Trend 3 days ago
75%
MACD
ODDS (%)
Bullish Trend 3 days ago
88%
Bullish Trend 3 days ago
69%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
84%
Bullish Trend 3 days ago
51%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
78%
Bullish Trend 3 days ago
43%
Advances
ODDS (%)
Bullish Trend 3 days ago
82%
Bullish Trend 12 days ago
75%
Declines
ODDS (%)
N/A
Bearish Trend 14 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
64%
Aroon
ODDS (%)
N/A
Bullish Trend 3 days ago
9%
View a ticker or compare two or three
Interact to see
Advertisement
SNPX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ZVSA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
MLAB98.672.31
+2.40%
Mesa Laboratories
VIV11.110.11
+1.00%
Telefonica Brasil SA
RLX2.220.02
+0.91%
RLX Technology
TRAW1.43N/A
N/A
Traws Pharma Inc
BW0.97-0.07
-6.90%
Babcock & Wilcox Enterprises

SNPX and

Correlation & Price change

A.I.dvisor indicates that over the last year, SNPX has been closely correlated with CDTX. These tickers have moved in lockstep 93% of the time. This A.I.-generated data suggests there is a high statistical probability that if SNPX jumps, then CDTX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SNPX
1D Price
Change %
SNPX100%
+23.37%
CDTX - SNPX
93%
Closely correlated
+0.24%
WINT - SNPX
92%
Closely correlated
+21.49%
NCNA - SNPX
92%
Closely correlated
N/A
NBY - SNPX
91%
Closely correlated
+0.97%
RNAC - SNPX
91%
Closely correlated
-6.81%
More

ZVSA and

Correlation & Price change

A.I.dvisor indicates that over the last year, ZVSA has been closely correlated with CDTX. These tickers have moved in lockstep 83% of the time. This A.I.-generated data suggests there is a high statistical probability that if ZVSA jumps, then CDTX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ZVSA
1D Price
Change %
ZVSA100%
+4.86%
CDTX - ZVSA
83%
Closely correlated
+0.24%
NCNA - ZVSA
82%
Closely correlated
N/A
SNPX - ZVSA
81%
Closely correlated
+23.37%
WINT - ZVSA
80%
Closely correlated
+21.49%
SCNI - ZVSA
79%
Closely correlated
-7.69%
More